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Abstract
Objectives—An algorithm for making a differential diagnosis between sustained and white coat
hypertension (SH and WCH) has been proposed–patients with office hypertension undergo home
blood pressure monitoring (HBPM) and those with normal HBP levels undergo ambulatory blood
pressure monitoring (ABPM). We tested whether incorporating an upper office blood pressure (OBP)
cutoff in the algorithm, higher than the traditional 140/90 mmHg, reduces the need for HBPM and
ABPM.
Methods—229 normotensive and untreated mildly hypertensive participants (mean age 52.5 ± 14.6,
54% female) underwent OBP measurements, HBPM, and 24-hour ABPM. Using the algorithm,
sensitivity (SN), specificity (SP), and positive and negative predictive values (PPV, NPV) for SH
and WCH were assessed. We then modified the algorithm utilizing a systolic and diastolic OBP
cutoff at a SP of 95% for ambulatory hypertension –those with office hypertension but OBP levels
below the upper cutoff undergo HBPM and subsequent ABPM if appropriate.
Results—Using the original algorithm, SN and PPV for SH were 100% and 93.8%. Despite a SP
of 44.4%, NPV was 100%. These values correspond to SP, NPV, SN, and PPV for WCH respectively.
Using the modified algorithm, the diagnostic accuracy for SH and WCH did not change. However,
far fewer participants needed HBPM (29 vs. 84) and ABPM (8 vs. 15).
Conclusions—In this sample, the original and modified algorithms are excellent at diagnosing SH
and WCH. However, the latter requires far fewer subjects to undergo HBPM and ABPM. These
findings have important implications for the cost-effective diagnosis of SH and WCH.
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Elevated blood pressure is a strong, independent risk factor for incident cardiovascular disease
[1]. Traditionally, the prognostic value of elevated blood pressure is based on the method of
taking auscultatory measurements in an office setting [2]. However, compared to office blood
pressures (OBP), ambulatory blood pressure (ABP) is a better predictor of target end-organ
damage and cardiovascular events [3,4,5]. Further, not all patients who receive a diagnosis of
hypertension on the basis of OBP assessments actually have elevated ABP levels, measured
by ABP monitoring (ABPM) [6]. These issues pose a difficult diagnostic dilemma for clinicians
who are seeking to differentiate patients with sustained hypertension (SH, office and
ambulatory hypertension) from those with “white coat” hypertension (WCH, office
hypertension with normal ABP levels), for whom antihypertensive drug treatment may be
inappropriate.
Because of the obvious advantages of ABPM, it is considered by most researchers and
clinicians to be the “gold standard” methodology for the non-invasive assessment of blood
pressure, and is recommended for the differential diagnosis of SH and WCH [6,7]. However,
ABPM is too expensive and impractical to be used for all patients presenting with office
hypertension. It has been suggested that home blood pressure monitoring (HBPM) is a viable
alternative [2,8]. As with ABP, the risks of target end-organ damage and cardiovascular events
are more strongly associated with home blood pressure (HBP) than with OBP [9,10,11].
Additionally, HBPM is affordable, practical, and widely available. Thus, HBPM may be a
useful alternative to ABPM for the assessment of SH and WCH.
In 1990, Dr. Thomas Pickering proposed an algorithm in which HBPM is used as a screening
test in patients who are diagnosed with office hypertension - those with elevated HBP would
be assumed to have SH, and those with normal HBP would undergo ABPM for a definitive
diagnosis [12]. Such an algorithm, if implemented, could have important implications for the
assessment of SH and WCH. However, a recent study by Stergiou et al. [13] suggested that
this strategy has limited diagnostic value for identifying WCH. Therefore, other than
performing ABPM in all patients with office hypertension, the most efficient and accurate way
to diagnose SH and WCH remains unknown.
Some evidence suggests that there is an upper level of OBP, higher than the traditional 140/90
mmHg, that makes ambulatory hypertension more likely [14,15,16,17,18]. While there are
obvious pitfalls in relying on OBP alone, the identification of an upper OBP threshold might
obviate the need for performing HBPM as well as subsequent ABPM in patients whose OBP
was above the threshold. However, the predictive value of an upper cutoff for OBP for
identifying ambulatory hypertension remains poorly characterized. Further, whether an OBP
cutoff would improve the efficiency and accuracy of the diagnostic algorithm remains
unknown. Therefore, the aim of the present study was to assess the predictive value of a higher
OBP cutoff in the diagnosis of ambulatory hypertension, and to determine the value of
incorporating an upper OBP cutoff in the proposed algorithm to differentiate SH from WCH.
Methods
Subject Recruitment
This study was conducted as previously described [8,19]; the relevant methods are briefly
described here. Participants were eligible if they: (1) were normotensive or had Stage 1
hypertension (140–159 mmHg/90–99 mmHg), according to Joint National Committee (JNC
VI) criteria, (2) were aged 18 to 80 years, (3) were willing, with physician’s permission, to
come off antihypertensive medication (if treated) for 2 weeks prior to the first study visit, and
to remain off for the duration of the study, and (4) had no history of overt cardiovascular disease.
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Hypertensive participants were recruited from the Weill Cornell Hypertension Center of New
York Presbyterian Hospital and from the Hypertension Center at Mount Sinai Medical Center
in New York City. Normotensive participants were recruited through advertisements. Written
informed consent was obtained from all subjects, and the study was approved by the
Institutional Review Boards of Weill Medical College of Cornell University and Mount Sinai
School of Medicine.
A total of 329 participants, enrolled between June 1998 and August 2003, underwent
measurements of OBP and ABPM. HBPM was performed in a subset of 229 subjects. Table
1 shows the baseline characteristics of the study population (n=229), including their average
systolic and diastolic blood pressures (SBP, DBP) measured at the office, by ABPM, and by
HBPM.
Study Procedures
The study consisted of three visits, separated by one-month intervals. Each study visit occurred
over two consecutive days (Days 1 and 2). On the first study visit, starting on Day 1, ABP
measurements were performed using an oscillometric ABP monitor (SpaceLabs Model 90207,
Redmond, WA) over a period of 36 hours. For about three-quarters of the recordings, the
ABPM was programmed to take a blood pressure reading every 30 minutes throughout the
monitoring period. For the remaining recordings, measurements were taken at 15-minute
intervals, between 6 A.M. and 10 P.M, and every 30 minutes between 10 P.M. and 6 A.M. For
the present analyses, we restricted the ABPM readings to the first 24 hours. Awake SBP and
DBP levels were defined based on diary reports of the times subjects woke up and went to
sleep. The mean number of valid measurements used to compute the mean awake ABP
measures was 33.4±11.8.
The subject, still wearing the ABP monitor, returned the next day (Day 2) to the Hypertension
Clinic where physician-obtained OBP readings were taken. The participant was escorted into
an examination room and rested for at least 5 minutes in the seated position, after which the
physician entered and took three OBP measurements using a mercury column
sphygmomanometer and stethoscope. The same physician (TGP) took the mercury-column BP
measurements on all occasions. For all OBP measurements, the participant sat in a straight-
backed chair with adjustable armrests. The participant sat with feet uncrossed on the floor, and
the arm supported at heart level, using the adjustable arm supports. The participant then left
the Hypertension Clinic, still wearing the ABPM, which s/he was instructed to remove at
bedtime that evening, and return via a prepaid mailer.
After the initial ABP recording, HBPM was performed over a 10-week period using, an
automatic, oscillometric HBP monitor (Omron HEM-747 IC, Omron Health Care, Vernon
Hills, IL), which has previously been validated [20,21,22]. The HBP monitor contained a built-
in modem that provided a telephone link to a server located at LifeLink Monitoring, Inc.
(Bearsville, NY) [23,24]. The monitor time- and date-stamped each reading, and could store
up to 125 readings in memory. Readings could not be edited by the participant. Once the
measurements were received by the server, a report was generated and faxed to our laboratory.
Participants were instructed to take three HBP measurements on four days a week in the
morning and again in the evening; they were also asked to take three additional measurements
on two occasions (at mid-morning and mid-afternoon) on two days a week, for a total of 36
measurements a week. The mean number of valid HBP readings per subject was 267.2±115.4.
For our study, analyses were performed with the HBP levels averaged over the first 12
assessments. A recently published systematic review [25] and an AHA/ASH/PCNA scientific
statement [26] concluded that the minimum number of home measurements, needed to obtain
a reliable estimate of a subject’s usual blood pressure, is 12. Results for these analyses were
not different than with the full set or an intermediate number (i.e. 30) of HBP readings.
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ABP and OBP assessments were repeated at the second and third study visits. For the purposes
of this study, the following blood pressures were utilized in the analyses: OBP measurements
performed at the first and second visits (for a total of 6 readings), ABP measurement performed
at the first study visit, and the HBP measurements. Office hypertension was defined as a
persistently elevated OBP (SBP ≥140 mmHg or DBP ≥90 mmHg), accordingly to the mean of
the 3 blood pressures at each study visit. Awake ambulatory hypertension and home
hypertension were defined as SBP ≥135 or DBP ≥85 mmHg, based on internationally accepted
limits [2,27]. SH was defined as meeting criteria for both office hypertension and ambulatory
hypertension. WCH was defined as meeting criteria for office hypertension but having normal
awake ABP levels.
Statistical Analyses
Results are presented as mean ± SD. Fisher’s exact test and independent samples t-tests were
used to compare proportions and means respectively. We used receiver-operating-
characteristic (ROC) curves [28] to identify systolic and diastolic OBP cutoffs (using the mean
of the 6 blood pressures from both study visits) for the diagnosis of ambulatory hypertension.
Because combinations of systolic and diastolic OBP are likely to have independent predictive
values, we incorporated both blood pressure measures in the ROC curve analysis, instead of
using either systolic or diastolic OBP. Logistic regression was used to predict awake
ambulatory hypertension from systolic and diastolic OBP. Predicted probabilities for
ambulatory hypertension were then generated for each subject based on his/her systolic and
diastolic OBP levels. A ROC curve analysis was used to determine sensitivities and specificities
for different predicted probability cutoffs for ambulatory hypertension. We determined the
probability cutoffs that yielded a specificity of 95% or greater for ambulatory hypertension (or
equivalently a sensitivity of 95% or greater for normal ABP). A specificity of 95% for
ambulatory hypertension is equivalent to a false positive rate of 5%. The SBP and DBP
boundary, representing the probability cutoff that yielded a specificity of 95% for ambulatory
hypertension, was then estimated by using the logistic regression equation: ln (cutoff p/(1−
cutoff p)) = β sysOBP (systolic OBP) + β diasOBP (diastolic OBP) + intercept. Using this equation,
one can generate the upper boundary in a graph by calculating systolic OBP values (on the
ordinate axis) from diastolic OBP values (on the abscissa axis), because the probability cutoff,
βsysOBP, βdiasOBP, and the intercept are known.
In participants with office hypertension (persistently elevated systolic OBP ≥140 or diastolic
OBP ≥90 mmHg), the proposed strategy of first using HBPM as an initial screening test and
then performing ABPM only in those with normal HBP levels (SBP <135 and DBP <85
mmHg), was assessed [12]. The algorithm was then re-examined by utilizing HBPM as a
screening test only in those participants with office hypertension whose mean OBP levels were
below the 95% specificity boundary for ambulatory hypertension.
Results
The sample was middle aged, and 54.1% were female (see Table 1). There were not significant
differences between OBP (average of the six OBP measurements) and HBP levels for SBP
[0.3 (95% CI −1.6 to 2.3) mmHg, p=0.75] or DBP [0.8 (95% CI −0.6 to 2.1) mmHg, p=0.28].
Systolic HBP levels were 1.6 (95% CI 0.1 to 3.1) mmHg lower than awake ABP (p=0.04). For
DBP, there was not a significant difference between HBP and awake ABP levels [−0.7 (95%
CI −1.9 to 0.4) mmHg, p=0.21]. Additionally, no significant differences were observed
between OBP and awake ABP levels for SBP [−1.3 (95% CI −3.1 to 0.6) mmHg, p=0.18] or
DBP [−0.0 (95% CI −1.1 to 1.1) mmHg, p=0.99].
In the 84 participants with office hypertension, mean OBP levels (average of the six OBP
measurements) were 154 ± 14/92 ± 9 mmHg. HBP levels were 8.5 (95% CI 4.9 to 12.1) mmHg
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and 5.3 (95% CI 2.8 to 7.9) mmHg lower than OBP levels for both SBP and DBP respectively
(ps<0.001). There were no differences between HBP and awake ABP levels for SBP [−0.1
(95% CI −3.0 to 2.9) mmHg; p=0.96] or DBP [−0.5 (95% CI −2.9 to 1.9) mmHg; p=0.65].
Finally, OBP levels were 8.4 (95% CI 5.1 to 11.8) mmHg and 4.8 (95% CI 2.9 to 6.7) mmHg
higher than awake ABP levels for both SBP and DBP respectively (ps<0.001).
95% Specificity Cutoff in OBP Levels for Identifying Participants with Ambulatory
Hypertension
As expected, both systolic and diastolic OBP were significant independent predictors of
ambulatory hypertension [OR 1.40 (95% CI 1.22–1.60) for each 5 mmHg increase in SBP, p<.
001; OR 1.38 (95% CI 1.10–1.72) for each 5 mmHg increase in DBP, p=.004]. Figure 1 shows
the ROC curve summarizing the ability of different combinations of systolic and diastolic OBP
levels to correctly diagnose ambulatory hypertension. The area under the ROC curve
(equivalent to the C-index) is 0.863. Figure 2 shows the scatterplot of systolic OBP versus
diastolic OBP. The 95% specificity boundary for ambulatory hypertension is shown in the
scatter plot (solid line, Figure 2). By design, only 5% of the participants with ambulatory
normotension (solid circles, Figure 2) had OBP levels above this line (Region A). Of the 229
participants (Regions A and B, Figure 2), 57 (24.9%) had systolic and diastolic OBP in Region
A. For these 57 participants, the mean systolic and diastolic OBP were 159 ± 12 mmHg and
96 ± 7 mmHg respectively. Systolic and diastolic OBP ranged from 141 to 204 mmHg, and 83
to 112 mmHg, respectively. In addition, 55 (96.5%) of the 57 participants in Region A had
office hypertension; and 52 (91.2%) had ambulatory hypertension (crosses, Figure 2) - this
percentage represents the positive predictive value of using the 95% specificity OBP cutoff for
the diagnosis of ambulatory hypertension.
Identifying Participants with Sustained Hypertension and White Coat Hypertension Using
the Original Algorithm
Figure 3 shows the breakdown of participants depending on diagnosis by OBP assessment,
HBPM, and ABPM. Of the 84 subjects with office hypertension, 75 (89.3%) had SH and 9
(10.7%) had WCH. Based on our original algorithm, which proposes HBPM for everyone with
elevated OBP levels, and ABPM only if HBP levels are normal, 15 subjects would have ABPM
and 11 of these (73%) would be found to have ambulatory hypertension, and hence SH. The
sensitivity and positive predictive value of this algorithm for detecting SH are 100% (75/75;
95% CI 96–100%) and 93.8% (75/80; 95% CI 88–98%) respectively. Although the specificity
for diagnosing SH is only 44.4% (4/9; 95% CI 15–77%), the negative predictive value is 100%
(4/4; 95% CI 40–100%). Conceptually, the sensitivity, specificity, positive predictive value,
and negative predictive value for the diagnosis of SH are equivalent to the specificity,
sensitivity, negative predictive value, and positive predictive value respectively for the
diagnosis of WCH. Hence, the sensitivity and positive predictive value for WCH are 44.4%
and 100% respectively. Also, the specificity for diagnosing WCH is 100% and the negative
predictive value is 93.8%.
Identifying Participants with Sustained Hypertension and White Coat Hypertension Using
the 95% Specificity Boundary in OBP Levels for Ambulatory Hypertension
Figure 4 shows the breakdown of participants after modifying the algorithm utilizing the 95%
specificity boundary for ambulatory hypertension. Of the 84 participants with office
hypertension, 55 (65.5%) had OBP levels above this boundary - 51 (92.7%) of the 55 subjects
had SH. Given that the modified algorithm does not mandate HBPM nor ABPM for these latter
subjects, out-of-office testing would be performed in many fewer people, compared to the
original algorithm (Figure 3 and 4; 29 vs. 84 for HBPM and 8 vs. 15 for ABPM). Further, the
sensitivity and positive predictive value of the modified algorithm for SH are similar to the
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original algorithm: 100% (75/75; 95% CI 96–100%) and 92.6% (75/81; 95% CI 84–97%)
respectively. Although the specificity for diagnosing SH is only 33.3% (3/9; 95% CI 9–69%),
the negative predictive value is 100% (3/3; 95% CI 31–100%). Equivalently, the sensitivity
and positive predictive value for WCH are 33.3% and 100% respectively. Also, the specificity
for diagnosing WCH is 100% and the negative predictive value is 92.6%.
Discussion
Our study confirms that ambulatory hypertension is more common in patients with higher
levels of OBP [14,15,17,18]. We have also used an ROC curve analysis to demonstrate that
we can utilize both systolic and diastolic OBP levels to identify a 95% specificity cutpoint that
minimizes the false positive rate (5%) and maximizes the positive predictive value (91.2%)
for the diagnosis of ambulatory hypertension, making SH likely and WCH unlikely.
In those diagnosed as hypertensive based on OBP levels, the original diagnostic algorithm has
excellent sensitivity, and positive and negative predictive values for SH; and, equivalently,
excellent specificity, and positive and negative predictive values for WCH. Having identified
a cutpoint for OBP which makes ambulatory hypertension very likely, the results of our study
suggest that it would be advantageous to incorporate this OBP cutpoint into the proposed
algorithm to diagnose SH and exclude WCH. By doing so, it may be possible to avoid out-of-
office testing with either HBPM or ABPM, for diagnostic purposes, in a large proportion of
patients with office hypertension. Further, the predictive values for both SH and WCH remain
excellent, suggesting an advantageous cost-effectiveness ratio for the newly proposed
algorithm.
HBPM has been proposed as an adjunct to OBP measurements in the clinical setting [29,30].
The rationale behind this approach is the difficulty of conducting ABPM in all patients with
office hypertension. Also, the ease and lower cost of HBPM makes it an ideal diagnostic test
prior to ABPM. Further, many HBP monitors have passed the British Hypertension Society
and American Association of Medical Instrumentation validation criteria [31,32]. In our study,
approximately 70–80% of the participants who undergo HBPM (Figures 3 and 4) may be able
to avoid ABPM because of the presence of home hypertension, a large proportion of whom
also have SH. Similar diagnostic accuracy of HBPM in predicting ambulatory hypertension or
normotension in those with office hypertension has been observed in other studies [33,34,
35]. In our study, a small percentage of the participants diagnosed with home hypertension
have normal ABP levels (Figures 3 and 4). However, these participants, technically labeled as
having WCH (office hypertension with normal ABP levels), may still be at increased risk for
cardiovascular events, as recent evidence suggests that elevated HBP levels are associated with
increased cardiovascular mortality, independent of ABP [36]. Therefore, HBPM may be both
a valuable diagnostic and prognostic test for patients presenting with office hypertension.
One potential limitation of the original and modified algorithms is that the specificity for SH,
and sensitivity for WCH are low. However, the positive and negative predictive values for both
SH and WCH are high. The excellent positive predictive value for SH is explained by both a
high true positive rate and a relatively low prevalence of WCH in our sample (10.7% of the
participants with office hypertension). The high negative predictive value is explained by a
very low false negative rate. Similarly, for the diagnosis of WCH, the sensitivity is low, yet
the positive predictive value is high - this is explained by a low false positive rate. The high
negative predictive value is additionally explained by a high true negative rate and relatively
low prevalence of WCH in this sample.
Although the prevalence of WCH in our sample is consistent with a number of published studies
[37,38,39], other studies have reported a higher prevalence of WCH [40,41,42]. In a previous
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study by Stergiou et al. [13] that tested the original algorithm in untreated patients with office
hypertension, similar specificity (100%), sensitivity (61%), and positive predictive value
(100%) for WCH were observed. However, in contrast, the negative predictive value of the
algorithm for WCH was lower (77%) than observed in our study (94.9%). The modest negative
predictive value in the study by Stergiou et al. [13] is most likely explained by a much higher
prevalence (38%) of WCH in their sample. Assuming a 38% prevalence of WCH in our study,
but the same sensitivity (44.4%) and specificity (100%), we find that the negative predictive
value falls from 93.8% to 78%, which is consistent with the findings by Stergiou et al [13].
Therefore, in a population in which the prevalence of WCH is higher, it is easier to diagnose,
but at the same time, more difficult to exclude. Conversely, SH is easier to exclude, but also
is more difficult to diagnose. Thus, the utility of the algorithm must be put in context of the
underlying prevalence of WCH in the population being evaluated.
There are a number of explanations as to why the prevalence of WCH was relatively low in
our study. OBP measurements can be substantially affected by differences in subject
preparation, arm position, cuff placement, number of readings, number of visits, and the
number and type (trained vs. untrained) of observers [2,26,43]. In our study, OBP readings
were obtained by the same trained physician with the careful preparation of the subject and
use of standardized measurement techniques. Also, three OBP readings were obtained at each
of two visits. Data suggest that repeated OBP assessments reduce the prevalence of WCH
[44]. This latter factor probably played an important role in our study. Office hypertension was
defined as a persistently elevated systolic OBP ≥140 mmHg or diastolic OBP ≥90 mmHg,
based on the mean of the 3 blood pressure readings at each visit. When we redefine office
hypertension as an elevated OBP (≥ 140/90 mmHg) at the first visit only, we find that instead
of 84 participants, 110 participants are diagnosed as having office hypertensive, and 19 (17.3%)
of these participants have WCH. While this relaxed criterion for office hypertension increases
the likelihood of having WCH, our original approach is more consistent with published
guidelines, which recommend the performance of high quality OBP measurements, over
multiple visits, in order to diagnose office hypertension [2,26,43].
It is noteworthy that the study by Stergiou et al. [13] was also conducted under carefully
controlled conditions, yet a WCH prevalence of 38% was noted. However, the study was based
on data from an earlier study conducted by Stergiou et al. [45] in which a prevalence rate of
11% for WCH (our prevalence was 10.7%) was observed when using similar OBP and ABP
cutoffs as in our study. The reasons for the difference in WCH prevalence rates are unknown
but may be explained by how office hypertension and ambulatory hypertension were defined,
which differed somewhat across the 2 studies [13,45].
Overall, for the assessment of SH and WCH, the original and modified versions of the algorithm
may have the greatest utility in populations where lower rates of WCH may be seen [15,37,
38,39]. Based on our results, it is tempting to recommend using Figure 2 and the modified
algorithm in routine clinical practice for diagnosing SH (and excluding WCH) in patients
presenting with elevated OBP levels. However, our analysis should be replicated in larger
outpatient clinic samples prior to the widespread dissemination of this diagnostic strategy.
Readings obtained from OBP assessments may be more variable in clinical practice than within
the context of a research study. However, we believe that this variability is minimized when
standard recommendations about OBP measurements are followed, as strongly suggested by
our study. Thus, the performance of multiple, high quality measurements of OBP is not simply
an adjunct, but is an essential part of a sound diagnostic algorithm for SH and WCH.
Finally, no differences in OBP and awake ABP levels were seen in the entire sample. This
finding may seem unusual since other studies have shown that physician-measured blood
pressures (OBP) are higher than awake ABP levels (i.e. a positive white coat effect). However,
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a positive white coat effect is generally observed in hypertensive individuals [16,46,47],
whereas either no or a negative white coat effect tends to be observed in normotensive
individuals [16,48]. It is important to note that our sample included subjects with normal OBP,
and in the 84 subjects with office hypertension, we indeed find a positive white coat effect.
This is consistent with the study by Verdecchia et al. [16] demonstrating that the positive white
coat effect is disproportionally seen in patients with office hypertension, and that the magnitude
of the white coat effect increases with higher levels of OBP. Nevertheless, the prevalence of
white coat hypertension in patients with office hypertension decreases with increasing levels
of OBP, despite a greater white coat effect, due to a concomitant higher prevalence of
ambulatory hypertension. Results from an international database also showed that higher levels
of OBP are associated with higher ABP levels in hypertensive subjects [17,18]. Our results are
completely consistent with these findings.
A few potential limitations of our study should be noted. First, we have considered one ABP
assessment as the ”gold standard” for the diagnosis of ambulatory hypertension. Although
some variability between monitoring sessions inevitably occurs, we chose to limit the ABP
assessment to one 24-hour period as a number of studies have found high test-retest reliability
for ABP levels [49,50]. Further, this approach is consistent with most of the studies linking
ABP levels to cardiovascular outcomes [3,5,51], and also with the way ABPM is most
commonly used in clinical practice. Second, in our study, the same diagnostic threshold (i.e.
135/85 mmHg) was used to classify home and ambulatory hypertension respectively. However,
it is generally accepted that the diagnostic threshold for both HBP and awake ABP is 135/85
mmHg [52,53]. Third, in our study, HBPM was originally based on hundreds of readings over
a 10-week period, however, we chose to limit the analyses to the first 12 HBP readings for a
number of reasons. The performance of hundreds of readings may not be feasible for many
patients. Further, a recently published systematic review [25] and scientific statement [26] both
concluded that the minimum number of home measurements required for a reliable estimate
of a subject’s average blood pressure is 12. Additionally, analyses were performed with the
full set of HBP readings as well as the HBP levels averaged over 30 assessments, and the results
were similar (data not shown). Fourth, our ROC curve analysis was conducted in all 229
participants rather than in the 84 participants with office hypertension; we did this in order to
obtain the most robust possible estimates of the relationship of OBP to ambulatory
hypertension. Excluding those with normal OBP, some of whom have ambulatory hypertension
could have biased the results. Nevertheless, an additional ROC analysis, restricted to those
with office hypertension was performed. While the diagnostic accuracy of the algorithm was
similar (data not shown), an additional 17 participants were required to undergo out-of-office
testing (HBPM and ABPM).
In conclusion, our findings suggest that the algorithm originally proposed in 1990 [12] is a
valid strategy for the assessment of SH and WCH in patients presenting with office
hypertension. The likelihood of ambulatory hypertension and SH increases at higher levels of
OBP. Further, we have demonstrated that incorporation of a higher OBP cutoff in the diagnostic
algorithm maintains the positive and negative predictive values while substantially decreasing
the number of patients that require out-of-office testing with HBPM and ABPM. In our sample,
the implementation of this modified algorithm would result in 65% fewer HBPM and 47%
fewer ABPM recordings needing to be performed, making it substantially a more cost-effective
strategy. We acknowledge that the negative predictive value for excluding WCH will be lower
in populations where the prevalence of WCH is high - a phenomenon that is characteristic of
all diagnostic tests [54,55]. Of course, both diagnostic algorithms require that OBP readings
be obtained by careful and standardized measurement techniques. Future research is needed
to validate our proposed upper OBP cutoffs, greater than the traditional 140/90 mmHg, for the
increased prediction of ambulatory hypertension in outpatient, clinical samples; and the cost-
effectiveness of the proposed strategy.
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Receiver-operating-characteristic curve analysis of predictive probabilities based on systolic
and diastolic OBP levels to diagnose ambulatory hypertension. Dotted lines represent 95%
confidence intervals.
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Scatter plot of systolic and diastolic OBP levels. Region A represents systolic and diastolic
OBP levels above the 95% specificity boundary for ambulatory hypertension. Region B
represents OBP levels outside of Region A. Solid circles and crosses represent participants
with normal ABP levels and participants with ambulatory hypertension respectively.
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Flow diagram of original algorithm using OBP and selected HBPM and ABPM to diagnose
SH and WCH. Bold lines represent the components of the algorithm. In patients with office
hypertension (systolic OBP ≥140 or diastolic OBP ≥90 mmHg, on two occasions), HBPM is
initially performed; ABPM is performed only in those with normal HBP levels (SBP <135 and
DBP <85 mmHg).
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Flow diagram of modified algorithm incorporating 95% specificity boundary for ambulatory
hypertension. Bold lines represent the components of the algorithm.
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Table 1
Sample characteristics*
Characteristics Total Sample (N=229)
Age, y 52.5 ± 14.6
Sex, % female 54.1
Race
 % White (Non-Hispanic) 60.7
 % White (Hispanic) 9.2
 % Black (Non-Hispanic) 17.5
 % Black (Hispanic) 1.7
 % Asian/Indian/Pacific Islander 6.1
 % Native American/Alaskan Native 0.4
 % Other 4.3
Office First visit Second visit Both visits†
 Systolic blood pressure, mmHg 134 ± 21 133 ± 22 133 ± 21
 Diastolic blood pressure, mmHg 83 ± 12 83 ± 13 83 ± 12
 % Hypertensive‡ 36.7
Ambulatory (awake)
 Systolic blood pressure, mmHg 135 ± 14
 Diastolic blood pressure, mmHg 83 ± 10
 % Hypertensive§ 57.6
Home
 Systolic blood pressure, mmHg 133 ± 18
 Diastolic blood pressure, mmHg 82 ± 11
 % Hypertensive§ 56.3
*
Data are expressed as percentage or mean ± SD.
†
Average of six OBP measurements (3 from first visit and 3 from second visit)
‡
Defined by having a mean systolic blood pressure ≥ 140 or diastolic blood pressure ≥ 90 mmHg on first visit and also second visit.
§
Defined by mean systolic blood pressure ≥ 135 or diastolic blood pressure ≥ 85 mmHg.
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